Latest News and Press Releases

Nassau, The Bahamas, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Bahamas Ministry of Tourism, Investments & Aviation is thrilled to announce the destination welcomed a record-breaking 11.22 million...

Taipei, Taiwan, May 15, 2024 (GLOBE NEWSWIRE) -- Semilux International Ltd. (“Semilux” or the “Company”) (NASDAQ: SELX), today announced that it filed its annual report on Form 20-F (the “Form...

Tel Aviv, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Jeffs’ Brands Ltd. (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon...

BEIJING, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) ("Cheer Holding," or the "Company"), a leading provider of advanced mobile internet infrastructure and platform...

New York, NY, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Hennessy Capital Investment Corp. VI (NASDAQ: HCVI) (the “Company”) today announced that its special meeting of the stockholders (the “Meeting”)...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY,...

Victoria, BC, Canada, July 21, 2022 (GLOBE NEWSWIRE) -- Highlights for fiscal year ending March 31, 2022: One-year annual return of 7.4%, representing $4.4 billion in added value Five-year...

Immunicum AB (“Immunicum” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på behandlingar mot tumörrecidiv och svårbehandlade etablerade tumörer, meddelar idag att årsredovisningen för 2021 nu...

Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that its Annual Report for...

Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the...